To provide an anti-C1q antibody capable of being used for the determination of a C1q protein, to provide a method for determining the C1q protein, to provide a kit therefor, to provide a pharmaceutical composition for treating or preventing an articular rheumatism, to provide a method for screening a substance for treating or preventing an articular rheumatism, to provide a kit therefor, and to provide a composition, a method, and a kit for the prognostic diagnosis of an articular rheumatism.
An anti-C1q monoclonal antibody capable of specifically recognizing a C1q protein, and a method for producing the same, a hybridoma for producing an anti-C1q monoclonal antibody, a method for determining the presence or quantity of a C1q protein in a sample with the anti-C1q monoclonal antibody and a kit therefor, a pharmaceutical composition containing a substance having C1q-binding activity for treating or preventing an articular rheumatis, a method for screening a substance for treating or preventing the articular rheumatism and a kit therefor, a composition conataining a substance having C1q-binding activity for the prognostic diagnosis of an articular rheumatism, a method for the prognostic diagnosis, and a kit therefor.
MMT KK
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita